METHOCARBAMOL
Generic: METHOCARBAMOL
FH2 PHARMA LLCManufacturer
ORALRoute
METHOCARBAMOLActive Substance
2023-06-12Original Approval
METHOCARBAMOL is FDA application ANDA212707, sponsored by PHARMOBEDIENT. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-03-21
Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset TherLack of Assurance of Sterility: Media fill with bacterial contamination
Class I2024-02-15
Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. iPresence of Particulate Matter
Top Reported Reactions
1
FATIGUE
1,273 reports
2
PAIN
1,246 reports
3
NAUSEA
1,192 reports
4
DRUG INEFFECTIVE
1,142 reports
5
HEADACHE
974 reports
6
DIARRHOEA
882 reports
7
OFF LABEL USE
837 reports
8
FALL
813 reports
9
DYSPNOEA
788 reports
10
ARTHRALGIA
767 reports